Is Ranbaxy and Sun Pharma same?
Is Ranbaxy and Sun Pharma same?
Sun Pharma completed the acquisition of Ranbaxy Laboratories Limited, an integrated, research based, international pharmaceutical company, on 25th March 2015.
What is the rank of Sun Pharma in India?
Top 10 Publicly Listed pharmaceutical companies in India by Market Capitalization as of 2021.
| Rank | Company | Market Capitalization 2021 (INR crores) |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 1,89,344 Crore |
| 2 | Divi’s Laboratories Ltd. | 1,38,297 Crore |
| 3 | Dr. Reddy’s Laboratories Ltd. | 81,525 Crore |
| 4 | Cipla Ltd. | 75,894 Crore |
When did Sun Pharmaceutical buy out Ranbaxy Laboratories?
On 7 April 2014, India-based Sun Pharmaceutical and Japan-based Daiichi Sankyo jointly announced the sale of the entire 63.4% share of Ranbaxy from Daiichi Sankyo to Sun Pharmaceutical in a $4 billion all-share deal. Under these agreements, shareholders of Ranbaxy were to receive a 0.8 share of Sun Pharmaceutical for each share of Ranbaxy.
Who is the current CEO of Ranbaxy Laboratories?
In November 2008, Daiichi-Sankyo completed the takeover of the company from the founding Singh family in a deal worth $4.6 billion by acquiring a 63.92% stake in Ranbaxy. Ranbaxy’s Malvinder Singh remained as CEO after the transaction.
Who are the founders of Sun Pharmaceutical Company?
Sun is the world’s fifth largest specialty generic pharmaceutical company. Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for Japanese company Shionogi. The name Ranbaxy is a portmanteau of the names of its founders: Ran bir and Gur bax. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax.
What kind of drugs did Ranbaxy Laboratories make?
Included in the adulterated products were antiretroviral (ARV) drugs destined for treatment of HIV/AIDS in Africa.